{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:59Z","timestamp":1772166239410,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC"],"award-info":[{"award-number":["NSFC"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960602"],"award-info":[{"award-number":["81960602"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangxi Science Fund for Distinguished Young Scholars","award":["2018GXNSFFA281001"],"award-info":[{"award-number":["2018GXNSFFA281001"]}]},{"name":"Guangxi Bagui Scholar"},{"name":"Guangxi Medical University Training Program for Distinguished Young Scholars"},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Plan","doi-asserted-by":"crossref","award":["GuikeAB18050022"],"award-info":[{"award-number":["GuikeAB18050022"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the impact of AIDS-defining events (ADE) on\u00a0long-term mortality of HIV positive individuals on antiretroviral therapy (ART), a retrospective HIV\/AIDS treatment cohort study performed in Southwestern China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The retrospective cohort was conducted among 6757 HIV\/AIDS patients on ART (2NRTIs\u2009+\u20091NNRTI, 2NRTIs\u2009+\u20091PI and Single or two drugs) recruited in Guigang city, Guangxi, China, from January 2004 to December 2018. Participants were divided into ADE and non-ADE groups, and were followed-up every six months to observe treatment outcomes. Comparison of mortality between groups was performed using the log-rank test and Kaplan\u2013Meier analysis. Cox proportional hazard regression was used to explore the risk factors of mortality. 1:1 propensity score matching (PSM) was used to balance confounding factors and adjust the mortality risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 6757 participants with 29,096.06 person-years of follow-up, 16.86% (1139\/6757) belonged to ADE group while the others (83.14%) belonged to the non-ADE group. The most common cause of death by ADE was disseminated mycosis (31.65%), followed by recurrent severe bacterial pneumonia (28.48%), herpes zoster (17.72%), and extra-pulmonary tuberculosis (8.86%). The mortality of the ADE group was significantly higher than that of the non-ADE group [3.45\/100 person-years (95% CI 2.92\u20133.97) vs. 2.34\/100 person-years (95% CI 2.15\u20132.52),\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.001]. The death risk of the ADE group was also higher than that of the non- ADE group [adjusted hazard ratio (aHR)\u2009=\u20091.291, 95% CI 1.061\u20131.571,\n                      <jats:italic>P\u2009<\/jats:italic>\n                      =\u20090.011], which was confirmed by PSM analysis (aHR\u2009=\u20091.581, 95% CI 1.192\u20132.099,\n                      <jats:italic>P\u2009<\/jats:italic>\n                      =\u20090.002). Cox analysis indicated that ADE, older age, male gender, previous non-use of cotrimoxazole, advanced WHO clinical stage, and low baseline CD4\n                      <jats:sup>+<\/jats:sup>\n                      cell count were the risk factors for death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Even on ART, the mortality risk of HIV positive individuals with ADE was higher than those without ADE. Active testing, earlier diagnosis, and timely therapy with ART may reduce the death risk of ADE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-020-00300-4","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T10:26:01Z","timestamp":1594981561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV\/AIDS patients in Southwestern China: a retrospective cohort study"],"prefix":"10.1186","volume":"17","author":[{"given":"Yunxuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oulu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuexiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunwei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingzhen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xionglin","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"300_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS. UNAIDS data 2018.Geneva: United Nations Publishing; 2018. https:\/\/www.unaids.org\/en\/resources\/documents\/2018\/unaids-data-2018."},{"key":"300_CR2","doi-asserted-by":"publisher","unstructured":"NCAIDS, NCSTD, China, CDC. Update on the AIDS\/STD epidemic in China in August, 2018; 24(10):965. Chinese Journal of AIDS & STD.2018; 24(10):965. https:\/\/doi.org\/10.13419\/j.cnki.aids.2018.10.01.","DOI":"10.13419\/j.cnki.aids.2018.10.01"},{"key":"300_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/13548506.2019.1616101","volume":"25","author":"W Da","year":"2020","unstructured":"Da W, Li X, Qiao S, Zhou Y, Shen Z. Antiretroviral therapy and mental health among people living with HIV\/AIDS in China. Psychol Health Med. 2020;25:45\u201352. https:\/\/doi.org\/10.1080\/13548506.2019.1616101.","journal-title":"Psychol Health Med"},{"issue":"1","key":"300_CR4","doi-asserted-by":"publisher","first-page":"7816","DOI":"10.1038\/s41598-019-44279-z","volume":"9","author":"J Jiang","year":"2019","unstructured":"Jiang J, Qin X, Liu H, Meng S, Abdullah AS, Huang J, et al. An optimal BMI range associated with a lower risk of mortality among HIV-infected adults initiating antiretroviral therapy in Guangxi, China. Sci Rep. 2019;9(1):7816.","journal-title":"Sci Rep."},{"issue":"7","key":"300_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1473-3099(11)70097-4","volume":"11","author":"F Zhang","year":"2011","unstructured":"Zhang F, Dou Z, Ma Y, Zhang Y, Zhao Y, Zhao D, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis. 2011;11(7):516\u201324.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 8","key":"300_CR6","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1097\/01.aids.0000304710.10036.2b","volume":"21","author":"F Zhang","year":"2007","unstructured":"Zhang F, Haberer JE, Wang Y, Zhao Y, Ma Y, Zhao D, et al. The Chinese free antiretroviral treatment program: challenges and responses. AIDS (London, England). 2007;21(Suppl 8):S143\u20138.","journal-title":"AIDS (London, England)"},{"issue":"Suppl 2","key":"300_CR7","doi-asserted-by":"publisher","first-page":"ii56","DOI":"10.1093\/ije\/dyq215","volume":"39","author":"Z Dou","year":"2010","unstructured":"Dou Z, Chen RY, Xu J, Ma Y, Jiao JH, Durako S, et al. Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09. Int J Epidemiol. 2010;39(Suppl 2):ii56\u201364. https:\/\/doi.org\/10.1093\/ije\/dyq215.","journal-title":"Int J Epidemiol."},{"issue":"1","key":"300_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12981-019-0221-7","volume":"16","author":"X Hu","year":"2019","unstructured":"Hu X, Liang B, Zhou C, Jiang J, Huang J, Ning C, et al. HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV\/AIDS in Southwestern China: a large-scale cross-sectional study. AIDS Res Ther. 2019;16(1):6.","journal-title":"AIDS Res Ther."},{"issue":"9","key":"300_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"The INSIGHT START Study Group","year":"2015","unstructured":"The INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807.","journal-title":"N Engl J Med"},{"issue":"01","key":"300_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.16506\/j.1009-6639","volume":"20","author":"GM Sun","year":"2019","unstructured":"Sun GM, Gu KK, Han ZHY. Life expectancy of 917 cases with HIV\/AIDS in Shanghai. Chin prev Med. 2019;20(01):32\u20136. https:\/\/doi.org\/10.16506\/j.1009-6639.","journal-title":"Chin prev Med."},{"issue":"11","key":"300_CR11","doi-asserted-by":"publisher","first-page":"e1080","DOI":"10.1016\/S2214-109X(17)30372-8","volume":"5","author":"A Badje","year":"2017","unstructured":"Badje A, Moh R, Gabillard D, Gu\u00e9hi C, Kabran M, Ntakp\u00e9 JB, et al. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial. Lancet Global Health. 2017;5(11):e1080\u20139.","journal-title":"Lancet Global Health."},{"issue":"1","key":"300_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12879-019-3844-3","volume":"19","author":"TD Mangal","year":"2019","unstructured":"Mangal TD, Meireles MV, Pascom ARP, de Almeida Coelho R, Benzaken AS, et al. Determinants of survival of people living with HIV\/AIDS on antiretroviral therapy in Brazil 2006\u20132015. BMC Infect Dis. 2019;19(1):206.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"300_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.4103\/jfmpc.jfmpc_411_18","volume":"8","author":"C Shriharsha","year":"2019","unstructured":"Shriharsha C, Rentala S. Quality of life among people living with HIV\/AIDS and its predictors: a cross-sectional study at ART center, Bagalkot, Karnataka. J Family Med Prim Care. 2019;8(3):1011\u20136.","journal-title":"J Family Med Prim Care."},{"issue":"1","key":"300_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12879-018-3026-8","volume":"18","author":"L Tao","year":"2018","unstructured":"Tao L, Liu M, Li S, Liu J, Wang N. Condom use in combination with ART can reduce HIV incidence and mortality of PLWHA among MSM: a study from Beijing, China. BMC Infect Dis. 2018;18(1):124.","journal-title":"BMC Infect Dis"},{"issue":"07","key":"300_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.11847\/zgggws1116546","volume":"24","author":"YY Xu","year":"2018","unstructured":"Xu YY, Zhu ZHP, Wu SS, Liu L, Guo L, Li X, et al. Survival of HIV\/AIDS patients receiving highly antiretroviral therapy in Nanjing city, 2004\u20132016. Chin J Public Health. 2018;24(07):697\u2013701. https:\/\/doi.org\/10.11847\/zgggws1116546.","journal-title":"Chin J Public Health."},{"issue":"12","key":"300_CR16","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.16462\/j.cnki.zhjbkz.2018.12.005","volume":"22","author":"XM Sun","year":"2018","unstructured":"Sun XM, Ma FH, Zhao JW, Zhuoma L, He Y, Dazheng C, et al. Survival analysis of adult HIV\/AIDS patients receiving antiviral treatment in Zhaojue. Chin J Dis Control Prev. 2018;22(12):1221\u20134. https:\/\/doi.org\/10.16462\/j.cnki.zhjbkz.2018.12.005.","journal-title":"Chin J Dis Control Prev."},{"issue":"12","key":"300_CR17","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.16462\/j.cnki.zhjbkz.2018.12.006","volume":"22","author":"J Chen","year":"2018","unstructured":"Chen J, Xu M, Zhao X, Huang CH, Lu HY. Analysis of the survival conditions of HIV\/AIDS patients receiving antiretroviral therapy in Beijing in 2005\u20132015 and the related factors. Chin J Dis Control Prev. 2018;22(12):1225\u20138. https:\/\/doi.org\/10.16462\/j.cnki.zhjbkz.2018.12.006.","journal-title":"Chin J Dis Control Prev."},{"issue":"7","key":"300_CR18","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3760\/cmaj.issn.0254-6450.2018.07.019","volume":"39","author":"Y Sun","year":"2018","unstructured":"Sun Y, Zhao QX, Li CF, Yang X, Zhang X, Liu CL, et al. Analysis on 10\u00a0year survival of HIV\/AIDS patients receiving antiretroviral therapy during 2003-2005 in Henan province. Chin J Epidemiol. 2018;39(7):966\u201370. https:\/\/doi.org\/10.3760\/cmaj.issn.0254-6450.2018.07.019.","journal-title":"Chin J Epidemiol."},{"issue":"1","key":"300_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3760\/cma.j.issn.0254-6450.2019.01.015","volume":"40","author":"N Zhang","year":"2019","unstructured":"Zhang N, Zhu XY, Wang GY, Tao XR, Wang N, Kang DM, et al. Survival status and influencing factors of HIV\/AIDS on highly active anti-retrovial therapy in Shandong province. Chin J Epidemiol. 2019;40(1):74\u20138. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2019.01.015.","journal-title":"Chin J Epidemiol."},{"issue":"2","key":"300_CR20","doi-asserted-by":"publisher","first-page":"e89861","DOI":"10.1371\/journal.pone.0089861","volume":"9","author":"A Cingolani","year":"2014","unstructured":"Cingolani A, Cozzi-Lepri A, Ammassari A, Mussini C, Ursitti MA, Caramello P, et al. Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort. PLoS ONE. 2014;9(2):e89861.","journal-title":"PLoS ONE."},{"key":"300_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2019.03.008","author":"WD Liu","year":"2019","unstructured":"Liu WD, Tsai WC, Hsu WT, Shih MC, Chen MY, Sun HY, et al. Impact of initiation of combination antiretroviral therapy according to the WHO recommendations on the survival of HIV-positive patients in Taiwan. J Microbiol Immunol Infect. 2019. https:\/\/doi.org\/10.1016\/j.jmii.2019.03.008.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"300_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/QAI.0000000000001571","volume":"77","author":"P Traisathit","year":"2018","unstructured":"Traisathit P, Delory T, Ngo-Giang-Huong N, Somsamai R, Techakunakorn P, Theansavettrakul S, et al. Brief report: AIDS-defining events and deaths in HIV-infected children and adolescents on antiretrovirals: a 14-year study in Thailand. J Acquir Immune Defic Syndr. 2018;77(1):17\u201322. https:\/\/doi.org\/10.1097\/QAI.0000000000001571.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"300_CR23","first-page":"1002491","volume":"15","author":"A Judd","year":"2018","unstructured":"Judd A, Chappell E, Turkova A, LeCoeur S, Noguera-Julian A, Goetghebuer T, et al. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: a cohort study. PLoS ONE. 2018;15(1):1002491.","journal-title":"PLoS ONE."},{"issue":"10","key":"300_CR24","doi-asserted-by":"publisher","first-page":"111400","DOI":"10.1371\/journal.pone.0111400","volume":"9","author":"FS Sarfo","year":"2014","unstructured":"Sarfo FS, Sarfo MA, Norman B, Phillips R, Bedu-Addo G, Chadwick D. Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy. PLoS ONE. 2014;9(10):111400.","journal-title":"PLoS ONE."},{"issue":"5","key":"300_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/QAI.0b013e3181a4f00d","volume":"51","author":"AH Anis","year":"2009","unstructured":"Anis AH, Nosyk B, Sun H, Guh DP, Bansback N, Li X, et al. Quality of life of patients with advanced HIV\/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events. J Acquir Immune Defic Syndr. 2009;51(5):631\u20139. https:\/\/doi.org\/10.1097\/QAI.0b013e3181a4f00d.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"300_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/infdis\/jiu417","volume":"211","author":"M Lichtner","year":"2015","unstructured":"Lichtner M, Cicconi P, Vita S, Galli M, Lo Caputo S, Saracino A, et al. Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J Infect Dis. 2015;211(2):178\u201386.","journal-title":"J Infect Dis."},{"issue":"10","key":"300_CR27","doi-asserted-by":"publisher","first-page":"e26009","DOI":"10.1371\/journal.pone.0026009","volume":"6","author":"JM Miro","year":"2011","unstructured":"Miro JM, Manzardo C, Mussini C, Johnson M, ArminioMonforte A, Antinori A, et al. Survival outcomes and effect of early vs deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis. PLoS ONE. 2011;6(10):e26009.","journal-title":"PLoS ONE."},{"key":"300_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/QAI.0b013e3181e8c129","volume":"55","author":"M Smurzynski","year":"2010","unstructured":"Smurzynski M, Wu K, Benson CA, Bosch RJ, Collier AC, Koletar SL. Relationship between CD4+ T-cell counts\/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study. Acquir Immune Defic Syndr. 2010;55:117\u201327.","journal-title":"Acquir Immune Defic Syndr."},{"key":"300_CR29","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1038\/s41598-017-03384-7","volume":"7","author":"Z Tang","year":"2017","unstructured":"Tang Z, Pan SW, Ruan Y, Liu X, Su J, Zhu Q, et al. Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study. Sci Rep. 2017;7:3129.","journal-title":"Sci Rep"},{"issue":"03","key":"300_CR30","first-page":"1","volume":"63","author":"Centers for Disease Control and Prevention (CDC)","year":"2014","unstructured":"Centers for Disease Control and Prevention (CDC). Revised surveillance case definition for HIV infection\u2013United States, 2014. MMWR Recomm Rep. 2014;63(03):1\u201310.","journal-title":"MMWR Recomm Rep."},{"key":"300_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1471-2334-13-200","volume":"13","author":"K Champenois","year":"2013","unstructured":"Champenois K, Cousien A, Cuzin L, Le Vu S, Deuffic-Burban S, Lanoy E, et al. Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study. BMC Infect Dis. 2013;13:200.","journal-title":"BMC Infect Dis"},{"key":"300_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jia2.25031","volume":"21","author":"AC Pettit","year":"2018","unstructured":"Pettit AC, Giganti MJ, Ingle SM, May MT, Shepherd BE, Gill MJ, et al. Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation. J Int AIDS Soc. 2018;21:1.","journal-title":"J Int AIDS Soc."},{"issue":"10","key":"300_CR33","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/cid\/ciw120","volume":"62","author":"B Dominguez-Molina","year":"2016","unstructured":"Dominguez-Molina B, Leon A, Rodriguez C, Benito JM, Lopez-Galindez C, Garcia F, et al. Analysis of non-AIDS-defining events in HIV controllers. Clin Infect Dis. 2016;62(10):1304\u20139.","journal-title":"Clin Infect Dis"},{"key":"300_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5897\/JAHR2017.0431","volume":"9","author":"H Belay","year":"2017","unstructured":"Belay H, Alemseged F, Angesom T, Hintsa S, Abay M. Effect of late HIV diagnosis on HIV-related mortality among adults in general hospitals of Central Zone Tigray, northern Ethiopia: a retrospective cohort study. HIV AIDS. 2017;9:187\u201392.","journal-title":"HIV AIDS."},{"key":"300_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwz252","author":"PF Belaunzaran-Zamudio","year":"2019","unstructured":"Belaunzaran-Zamudio PF, Caro-Vega YN, Shepherd BE, Rebeiro PF, Crabtree-Ram\u00edrez BE, Cortes CP, et al. The population impact of late presentation with advanced HIV disease and delayed antiretroviral therapy in adults receiving HIV care in Latin America. Am J Epidemiol. 2019. https:\/\/doi.org\/10.1093\/aje\/kwz252.","journal-title":"Am J Epidemiol."},{"issue":"5","key":"300_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0929-6646(11)60046-6","volume":"110","author":"Y-C Lo","year":"2011","unstructured":"Lo Y-C, Wu P-Y, Hsieh C-Y, Chen MY, Sheng WH, Hsieh SM, et al. Late diagnosis of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: role of socio-behavioral factors and medical encounters. J Formos Med Assoc. 2011;110(5):306\u201315.","journal-title":"J Formos Med Assoc"},{"issue":"13","key":"300_CR37","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1097\/QAD.0b013e32833c7b9c","volume":"24","author":"RD Smith","year":"2010","unstructured":"Smith RD, Delpech VC, Brown AE, Rice BD. HIV transmission and high rates of late diagnoses among adults aged 50\u00a0years and over. AIDS. 2010;24(13):2109\u201315.","journal-title":"AIDS."},{"issue":"7","key":"300_CR38","doi-asserted-by":"publisher","first-page":"e0200505","DOI":"10.1371\/journal.pone.0200505","volume":"13","author":"NF Telele","year":"2018","unstructured":"Telele NF, Kalu AW, Marrone G, Marrone G, Gebre-Selassie S, Fekade D, et al. Baseline predictors of antiretroviral treatment failure and lost to follow up in a multicenter countrywide HIV-1 cohort study in Ethiopia. PLoS ONE. 2018;13(7):e0200505.","journal-title":"PLoS ONE"},{"issue":"1","key":"300_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12879-019-4170-5","volume":"19","author":"YM Bezabih","year":"2019","unstructured":"Bezabih YM, Beyene F, Bezabhe WM. Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia. BMC Infect Dis. 2019;19(1):537.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"300_CR40","doi-asserted-by":"publisher","first-page":"e1001194","DOI":"10.1371\/journal.pmed.1001194","volume":"9","author":"J Young","year":"2012","unstructured":"Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, et al. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med. 2012;9(3):e1001194.","journal-title":"PLoS Med."},{"issue":"9","key":"300_CR41","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321(9):844\u20135.","journal-title":"JAMA."},{"issue":"9","key":"300_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"JD Lundgren","year":"2015","unstructured":"Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807.","journal-title":"N Engl J Med."},{"key":"300_CR43","doi-asserted-by":"crossref","unstructured":"Announcement: Monitoring Selected National HIV Prevention and Care Objectives. Morbidity Mortal Wkly Rep. 2017; 66(29):794.","DOI":"10.15585\/mmwr.mm6629a6"},{"issue":"25","key":"300_CR44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.15585\/mmwr.mm6825a2","volume":"68","author":"MA Pitasi","year":"2019","unstructured":"Pitasi MA, Delaney KP, Brooks JT, DiNenno EA, Johnson SD, Prejean J. HIV Testing in 50 local jurisdictions accounting for the majority of new HIV diagnoses and seven states with disproportionate occurrence of HIV in rural areas, 2016\u20132017. Morbidity Mortal Wkly Rep. 2019;68(25):561\u20137.","journal-title":"Morbidity Mortal Wkly Rep."},{"issue":"31","key":"300_CR45","doi-asserted-by":"publisher","first-page":"830","DOI":"10.15585\/mmwr.mm6631a3","volume":"66","author":"EA DiNenno","year":"2017","unstructured":"DiNenno EA, Prejean J, Irwin K, Delaney KP, Bowles K, Martin T, et al. Recommendations for HIV screening of gay, bisexual, and other men who have sex with men, United States, 2017. Morbidity Mortal Wkly Rep. 2017;66(31):830\u20132.","journal-title":"Morbidity Mortal Wkly Rep."}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-020-00300-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00300-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T20:03:12Z","timestamp":1626465792000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-020-00300-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1186\/s12981-020-00300-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-19533\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-19533\/v1","asserted-by":"object"}]},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Human Research Ethics Committee of Guangxi Medical University (Ethical Review No. 2019-SB-102).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}